ImmunityBio Inc. Common Stock vs Teucrium Soybean Fund — how do they compare? ImmunityBio Inc. Common Stock trades at $10.72 (market cap $10.51B), while Teucrium Soybean Fund trades at $27.48 (market cap $43.52M). The key difference: ImmunityBio Inc. Common Stock is far larger — about 241.5× Teucrium Soybean Fund's market cap, and Teucrium Soybean Fund is more actively traded (32,585 versus 10,445,785). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and Teucrium Soybean Fund for 23 Days on average.
| IBRX | SOYB | |
|---|---|---|
Market Cap | $10.51B | $43.52M |
Volume | 10,445,785 | 32,585 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $11.55 | $28.14 |
52-Week Low | $1.98 | $21.55 |
Typical Hold Time | 1 Days | 23 Days |
Enterprise Value | $10.97B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →